Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease

被引:27
|
作者
Zekonyte, Jurgita [1 ]
Sakai, Kenji [2 ]
Nicoll, James A. R. [3 ]
Weller, Roy O. [3 ]
Carare, Roxana O. [3 ]
机构
[1] Univ Southampton, Fac Engn & Environm, Southampton SO9 5NH, Hants, England
[2] Kanazawa Univ Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan
[3] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
Apolipoprotein E; Perivascular clearance pathways; Laminin; Atomic force microscopy; Amyloid-beta; Cerebral amyloid angiopathy; Alzheimer's disease; ISOFORM-SPECIFIC BINDING; APOLIPOPROTEIN-E; FORCE SPECTROSCOPY; ANGIOPATHY; PROTEIN; BRAIN; ATTACHMENT; CLEARANCE; DRAINAGE; REMOVAL;
D O I
10.1016/j.bbadis.2015.08.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of amyloid-beta (A beta) in plaques in the brain and in artery walls as cerebral amyloid angiopathy indicates a failure of elimination of A beta from the brain with age and Alzheimer's disease. A major pathway for elimination of A beta and other soluble metabolites from the brain is along basement membranes within the walls of cerebral arteries that represent the lymphatic drainage pathways for the brain. The motive force for the elimination of A beta along this perivascular pathway appears to be the contrary (reflection) wave that follows the arterial pulse wave. Following injection into brain parenchyma, A beta rapidly drains out of the brain along basement membranes in the walls of cerebral arteries; such drainage is impaired in apolipoprotein E epsilon 4 (ApoE4) mice. For drainage of A beta to occur in a direction contrary to the pulse wave, some form of attachment to basement membrane would be required to prevent reflux of A beta back into the brain during the passage of the subsequent pulse wave. In this study, we show first that apolipoprotein E co-localizes with A beta in basement membrane drainage pathways in the walls of arteries. Secondly, we show by Atomic Force Microscopy that attachment of ApoE4/A beta complexes to basement membrane laminin is significantly weaker than ApoE3/A beta complexes. These results suggest that perivascular elimination of ApoE4/A beta complexes would be less efficient than with other isoforms of apolipoprotein E, thus endowing a higher risk for Alzheimer's disease. Therapeutic correction for ApoE4/A beta/laminin interactions may increase the efficiency of elimination of A beta in the prevention of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock. (c) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 50 条
  • [1] The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer’s Disease
    Xianbo Zhuang
    Jie Lin
    Yamin Song
    Ru Ban
    Xin Zhao
    Zhangyong Xia
    Zheng Wang
    Guifeng Zhang
    NeuroMolecular Medicine, 27 (1)
  • [2] Presenilins, amyloid-beta and Alzheimer's disease
    Lamb, BT
    NATURE MEDICINE, 1997, 3 (01) : 28 - 29
  • [3] "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease
    Rao, Chinthalapally V.
    Asch, Adam S.
    Carr, Daniel J. J.
    Yamada, Hiroshi Y.
    AGING CELL, 2020, 19 (03)
  • [4] Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance
    Marr, Robert A.
    Hafez, Daniel M.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [5] Amyloid-beta antibody treatment in Alzheimer's disease
    Stoegmann, Elisabeth
    Schmidt, Reinhold
    WIENER KLINISCHE WOCHENSCHRIFT, 2024,
  • [6] Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
    Sadigh-Eteghad, Saeed
    Sabermarouf, Babak
    Majdi, Alireza
    Talebi, Mahnaz
    Farhoudi, Mehdi
    Mahmoudi, Javad
    MEDICAL PRINCIPLES AND PRACTICE, 2015, 24 (01) : 1 - 10
  • [7] Alzheimer's disease - The ins and outs of amyloid-beta
    Beyreuther, K
    Masters, CL
    NATURE, 1997, 389 (6652) : 677 - 678
  • [8] Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease
    Murphy, M. Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04): : 391 - 392
  • [9] Chylomicron amyloid-beta in the aetiology of Alzheimer's disease
    Takechi, R.
    Galloway, S.
    Pallebage-Gamarallage, M. M. S.
    Mamo, J. C. L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (02) : 19 - 25
  • [10] The molecular spectrum of amyloid-beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease
    Ichimata, Shojiro
    Yoshida, Koji
    Li, Jun
    Rogaeva, Ekaterina
    Lang, Anthony E.
    Kovacs, Gabor G.
    BRAIN PATHOLOGY, 2023,